DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Moehler M, Shitara K, Garrido M. et al.
Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1 L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study.
Ann Oncol 2020;
31 (Suppl. 04) S1142-S1215
DOI: 10.1016/annonc/annonc325. Abstract LBA6_PR
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.